166 related articles for article (PubMed ID: 16139422)
1. Treatment of intraventricular hemorrhage with intraventricular administration of recombinant tissue plasminogen activator A clinical study of 18 cases.
Vereecken KK; Van Havenbergh T; De Beuckelaar W; Parizel PM; Jorens PG
Clin Neurol Neurosurg; 2006 Jul; 108(5):451-5. PubMed ID: 16139422
[TBL] [Abstract][Full Text] [Related]
2. Lower dose intraventricular T-PA fibrinolysis: case report.
Deutsch H; Rodriguez JC; Titton RL
Surg Neurol; 2004 May; 61(5):460-3; discussion 463. PubMed ID: 15120223
[TBL] [Abstract][Full Text] [Related]
3. Cerebral venous congestion as indication for thrombolytic treatment.
Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
[TBL] [Abstract][Full Text] [Related]
4. Alteplase (rtPA) treatment of intraventricular hematoma (IVH): safety of an efficient methodological approach for rapid clot removal.
Bartek J; Hansen-Schwartz J; Bergdal O; Degn J; Romner B; Welling KL; Fischer W
Acta Neurochir Suppl; 2011; 111():409-13. PubMed ID: 21725792
[TBL] [Abstract][Full Text] [Related]
5. Intraventricular thrombolysis with rt-PA in patients with intraventricular hemorrhage.
Dunatov S; Antoncic I; Bralic M; Jurjevic A
Acta Neurol Scand; 2011 Nov; 124(5):343-8. PubMed ID: 21303348
[TBL] [Abstract][Full Text] [Related]
6. Intraoperative use of rtPA for subarachnoid hemorrhage.
Schmidt JH; Christenson JT
W V Med J; 1994 Mar; 90(3):98-100. PubMed ID: 8197745
[TBL] [Abstract][Full Text] [Related]
7. Effect of recombinant tissue plasminogen activator on clot lysis and ventricular dilatation in the treatment of severe intraventricular haemorrhage.
Mayfrank L; Lippitz B; Groth M; Bertalanffy H; Gilsbach JM
Acta Neurochir (Wien); 1993; 122(1-2):32-8. PubMed ID: 8333306
[TBL] [Abstract][Full Text] [Related]
8. Cerebral autoregulation dynamics in acute ischemic stroke after rtPA thrombolysis.
Reinhard M; Wihler C; Roth M; Harloff A; Niesen WD; Timmer J; Weiller C; Hetzel A
Cerebrovasc Dis; 2008; 26(2):147-55. PubMed ID: 18560218
[TBL] [Abstract][Full Text] [Related]
9. Cohort study of intraventricular thrombolysis with recombinant tissue plasminogen activator for aneurysmal intraventricular hemorrhage.
Findlay JM; Jacka MJ
Neurosurgery; 2004 Sep; 55(3):532-7; discussion 537-8. PubMed ID: 15335420
[TBL] [Abstract][Full Text] [Related]
10. [Thrombolytic therapy after intraventricular haemorrhage].
Gadegaard KH; Dahl BL; Hansen TS
Ugeskr Laeger; 2010 May; 172(19):1440-1. PubMed ID: 20470653
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of MRI-based selection for recombinant tissue plasminogen activator treatment: responder analysis of outcome in the 3-hour time window.
Sølling C; Hjort N; Ashkanian M; Østergaard L; Andersen G
Cerebrovasc Dis; 2009; 27(3):223-9. PubMed ID: 19176954
[TBL] [Abstract][Full Text] [Related]
12. Intraventricular thrombolysis for massive intraventricular hemorrhage due to periventricular arteriovenous malformations: no absolute contraindications as rescue therapy prior to surgical repair or embolization?
Jorens PG; Menovsky TM; Voormolen MH; Van Den Brande E; Parizel PM
Clin Neurol Neurosurg; 2009 Jul; 111(6):544-50. PubMed ID: 19328624
[TBL] [Abstract][Full Text] [Related]
13. Exacerbation of perihematomal edema and sterile meningitis with intraventricular administration of tissue plasminogen activator in patients with intracerebral hemorrhage.
Ducruet AF; Hickman ZL; Zacharia BE; Grobelny BT; Narula R; Guo KH; Claassen J; Lee K; Badjatia N; Mayer SA; Connolly ES
Neurosurgery; 2010 Apr; 66(4):648-55. PubMed ID: 20305489
[TBL] [Abstract][Full Text] [Related]
14. Acute stroke management in the elderly.
Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
[TBL] [Abstract][Full Text] [Related]
15. Fibrinolytic therapy versus craniotomy for anticoagulant-associated intracerebral hemorrhage.
Rohde V; Uzma N; Rohde I; St Clair E; Samadani U
Clin Neurol Neurosurg; 2009 Jul; 111(6):518-22. PubMed ID: 19297083
[TBL] [Abstract][Full Text] [Related]
16. Prospective, randomized, open-label phase II trial on concomitant intraventricular fibrinolysis and low-frequency rotation after severe subarachnoid hemorrhage.
Etminan N; Beseoglu K; Eicker SO; Turowski B; Steiger HJ; Hänggi D
Stroke; 2013 Aug; 44(8):2162-8. PubMed ID: 23735957
[TBL] [Abstract][Full Text] [Related]
17. Telephonic guidance of systemic thrombolysis in acute ischemic stroke: safety outcome in rural hospitals.
Vaishnav AG; Pettigrew LC; Ryan S
Clin Neurol Neurosurg; 2008 May; 110(5):451-4. PubMed ID: 18353532
[TBL] [Abstract][Full Text] [Related]
18. Intraventricular administration of rt-PA in patients with intraventricular hemorrhage.
Fountas KN; Kapsalaki EZ; Parish DC; Smith B; Smisson HF; Johnston KW; Robinson JS
South Med J; 2005 Aug; 98(8):767-73. PubMed ID: 16144170
[TBL] [Abstract][Full Text] [Related]
19. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
[TBL] [Abstract][Full Text] [Related]
20. Fibrinolytic therapy in spontaneous intraventricular haemorrhage: efficacy and safety of the treatment.
Torres A; Plans G; Martino J; Godino O; Garcia I; Gracia B; Acebes JJ
Br J Neurosurg; 2008 Apr; 22(2):269-74. PubMed ID: 18348024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
